Even though investors are encouraged to focus on the long term, timing
still has a lot to do with share price performance. In the case of
global (but UK-focused) insurance company
Aviva (NYSE:
AV),
timing really isn't on the company's side. While this looks like a
pretty respectable long-term business, balance sheet issues may well
force the company to sell assets at a time when valuations are quite
low.
Please read more here:
http://stocks.investopedia.com/stock-analysis/2012/Aviva-In-The-Wrong-Place-At-The-Wrong-Time-AV-PUK-HIG-MET0621.aspx
No comments:
Post a Comment